Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Studying Hydatidiform mole
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Principal Investigator
- Xing XieWomen's Hospital, Zhejiang University School of Medicine
- Intervention
- Follow up(other)
- Enrollment
- 30 enrolled
- Eligibility
- 60 years · FEMALE
- Timeline
- 2018 – 2030
Study locations (1)
- Weiguo Lv, Hangzhou, Zhejiang, China
Collaborators
Qilu Hospital of Shandong University · Tongji Hospital Affiliated to Tongji Medical College of HUST · The First People's Hospital of Yunnan · Tianjin Central Hospital of Gynecology Obstetrics · Women and Children's Hospital of Ningbo University · First Affiliated Hospital of Wenzhou Medical University · Hangzhou Fuyang Women And Children Hospital · Zhejiang Provincial Tongde Hospital · Shaoxing Shangyu Women And Children Hospital · Huzhou Maternity and Child Health Care Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03785574 on ClinicalTrials.govOther trials for Hydatidiform mole
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06113237Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During PregnancyJazz Pharmaceuticals
- ENROLLING BY INVITATIONNANCT05872022A Study to Evaluate Safety of Exposure to Wegovy During PregnancyNovo Nordisk A/S
- ACTIVE NOT RECRUITINGNCT05516810The Accuracy of Ultrasound Diagnosis of Hydatidiform MolesKing's College Hospital NHS Trust
- ACTIVE NOT RECRUITINGNCT01008501Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform MolesBaylor College of Medicine